New Peer-Reviewed Research Reinforces What the Data Has Shown for Years: Vaping Has Saved Canadian Lives

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions Saved Articles My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire New Peer-Reviewed Research Reinforces What the Data Has Shown for Years: Vaping Has Saved Canadian LivesAuthor of the article: You can save this article by registering for free here. Or sign-in if you have an account.Ottawa, ON, Aug. 10, 2026 (GLOBE NEWSWIRE) — In response to a recent wave of alarming media coverage about vaping, the Canadian Vaping Association (CVA) is urging journalists, policymakers, and the public to look past the headlines and toward the growing body of peer-reviewed research on nicotine vaping products (NVPs) as a smoking-cessation and harm-reduction tool. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountA study, Canada smoking and vaping model (SAVM): the public health impact of NVP availability in Canada, published this year in BMJ Public Health, built on Health Canada survey data using a validated simulation model known as the Canada Smoking and Vaping Model (SAVM), estimates that the legalization of nicotine vaping products under the 2018 Tobacco and Vaping Products Act has already helped prevent an estimated 125,300 smoking- and vaping-attributable deaths and preserve 2.6 million life-years for Canadians through 2060. Over that same period, smoking prevalence fell sharply among both men and women following legalization, a trend the study’s authors attribute in significant part to smokers switching to lower-risk vaping products. Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe study also found that smoking rates continued to decline among Canadian youth and young adults following the legalization of regulated nicotine vaping products. In fact, young adults experienced some of the largest reductions in smoking prevalence, suggesting that increased access to regulated vaping products coincided with fewer young Canadians smoking cigarettes. This finding is not an outlier. A separate 2025 economic analysis by researchers at the University of Missouri and Yale University found that the U.S. decision to exempt e-cigarettes from pharmaceutical drug regulation was associated with an estimated 677,000 life-years saved between 2011 and 2019, a benefit driven primarily by smokers switching away from combustible cigarettes. Extrapolated to Canada’s population, this represents approximately 41,962 life years saved per year. “The evidence is becoming increasingly difficult to ignore,” said Sam Tam, President of the CVA. “When adult smokers have access to regulated vaping products, fewer of them die from smoking-related illnesses. That is what two independent research teams, using two different countries’ data and two different methods, both found. Canadians deserve to hear that alongside the headlines.” The Tobacco and Vaping Products Act was designed with two public health objectives: protect youth from nicotine addiction while providing adult smokers with access to a less harmful alternative to cigarettes. Those goals are complementary, not contradictory, and effective policy should continue to advance both. Why Public Perception Doesn’t Always Match the Evidence A third study, Forget the science – you just know this is wrong! the moralization of vaping and trust in new scientific information, published in Addiction Research & Theory in 2025, offers a possible explanation for the gap between evidence and public perception referred to as “attitude moralization”. Researchers found that when people come to see vaping as morally wrong (rather than simply risky), they become significantly less willing to trust new scientific evidence about it, even independent of their general trust in science. Once an issue becomes moralized, in other words, evidence that contradicts the prevailing moral narrative can be dismissed regardless of its quality or source. This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.“This tells us something important about the current public conversation on vaping,” Sam Tam added. “It’s not that the science is weak or contested, it’s that vaping has become a moral issue in Canada, and that changes how people process new information. Our job is to make sure Canadians have access to the full body of evidence so they can make informed decisions.” The CVA acknowledges that questions remain about the long-term studies on the effects of vaping, and that the researchers behind the SAVM model themselves caution that their results depend on assumptions about smoking-to-vaping switching rates and call for continued monitoring as new data emerges. The CVA supports this ongoing research, while also striking a balance that prevents youth access and uptake through education and prevention efforts, including support for Health Canada’s ‘I Quit for Me’ program. Notably, youth vaping has already declined by nearly 60% from its 2019 peak, as reported in the 2024 Canadian Health Survey on Children and Youth (CHSCY). The Association maintains, however, that the core, well-supported finding that regulated vaping products help adult smokers quit combustible cigarettes, with measurable population-level health benefits deserves a place in public conversation. The CVA is calling on media outlets to include this research in their coverage of vaping, and on policymakers to weigh it as they consider future regulation that could affect Canada’s progress towards smoke-free status. For up-to-date information on the Canadian vaping industry and the latest ontobacco harm reduction, follow the CVA on X at @thecvaofficial Sam Tam The Canadian Vaping Association stam@thecva.org Ashley Bouman The Canadian Vaping Association abouman@thecva.org Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.